Solana PE Ratio 2014-2025 | HSDT
Current and historical p/e ratio for Solana (HSDT) from 2014 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Solana PE ratio as of November 13, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Solana PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-11-14 | 4.82 | 0.00 | |
| 2025-06-30 | 9.10 | $-1,976.28 | 0.00 |
| 2025-03-31 | 300.75 | $-2,376.31 | 0.00 |
| 2024-12-31 | 502.73 | $-4,302.85 | 0.00 |
| 2024-09-30 | 420.98 | $-4,632.68 | 0.00 |
| 2024-06-30 | 735.00 | $-8,006.00 | 0.00 |
| 2024-03-31 | 4372.50 | $-9,775.11 | 0.00 |
| 2023-12-31 | 6029.40 | $-10,839.58 | 0.00 |
| 2023-09-30 | 7117.50 | $-16,109.45 | 0.00 |
| 2023-06-30 | 7185.00 | $-16,491.76 | 0.00 |
| 2023-03-31 | 9555.00 | $-50,599.71 | 0.00 |
| 2022-12-31 | 11508.80 | $-90,329.85 | 0.00 |
| 2022-09-30 | 10331.20 | $-133,058.48 | 0.00 |
| 2022-06-30 | 44250.00 | $-203,898.07 | 0.00 |
| 2022-03-31 | 124125.00 | $-264,242.90 | 0.00 |
| 2021-12-31 | 194625.00 | $-282,983.53 | 0.00 |
| 2021-09-30 | 540000.00 | $-300,224.92 | 0.00 |
| 2021-06-30 | 637125.00 | $-329,730.28 | 0.00 |
| 2021-03-31 | 674625.00 | $-337,871.32 | 0.00 |
| 2020-12-31 | 494288.00 | $-472,607.24 | 0.00 |
| 2020-09-30 | 507806.00 | $-655,266.80 | 0.00 |
| 2020-06-30 | 560044.00 | $-838,741.50 | 0.00 |
| 2020-03-31 | 433125.00 | $-747,004.14 | 0.00 |
| 2019-12-31 | 1000000.00 | $-629,056.16 | 0.00 |
| 2019-09-30 | 1000000.00 | $-668,372.16 | 0.00 |
| 2019-06-30 | 1000000.00 | $-629,056.16 | 0.00 |
| 2019-03-31 | 1000000.00 | $-1,625,061.82 | 0.00 |
| 2018-12-31 | 1000000.00 | $-1,651,272.50 | 0.00 |
| 2018-09-30 | 1000000.00 | $-1,362,955.10 | 0.00 |
| 2018-06-30 | 1000000.00 | $-1,965,800.60 | 0.00 |
| 2018-03-31 | 1000000.00 | $-1,349,849.60 | 0.00 |
| 2017-12-31 | 1000000.00 | $-1,638,166.90 | 0.00 |
| 2017-09-30 | 1000000.00 | $-1,638,166.90 | 0.00 |
| 2017-06-30 | 1000000.00 | $-1,048,426.70 | 0.00 |
| 2017-03-31 | 1000000.00 | $-917,373.40 | 0.00 |
| 2016-12-31 | 1000000.00 | $-851,846.80 | 0.00 |
| 2016-09-30 | 1000000.00 | $-1,113,953.50 | 0.00 |
| 2016-06-30 | 1000000.00 | $-720,793.40 | 0.00 |
| 2016-03-31 | 1000000.00 | $-786,320.10 | 0.00 |
| 2015-12-31 | 1000000.00 | $-458,686.70 | 0.00 |
| 2015-09-30 | 1000000.00 | $-196,580.00 | 0.00 |
| 2015-06-30 | 1000000.00 | $-327,633.40 | 0.00 |
| 2015-03-31 | 1000000.00 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.005B | $0.001B |
| Helius Medical Technologies Inc. is a specialty medical device company. It is focused on the development and regulatory approval of its non-invasive neurostimulation device called PoNS. The Company is nearing clinical trials for balance disorders in TBI patients and for the treatment of MS. Helius Medical Technologies, Inc. is based in Newtown, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $217.960B | 25.90 |
| Intuitive Surgical (ISRG) | United States | $202.722B | 79.31 |
| IDEXX Laboratories (IDXX) | United States | $56.014B | 55.63 |
| Edwards Lifesciences (EW) | United States | $49.970B | 33.51 |
| Alcon (ALC) | Switzerland | $38.774B | 26.20 |
| IQVIA Holdings (IQV) | United States | $38.071B | 21.23 |
| Mettler-Toledo (MTD) | United States | $28.849B | 33.75 |
| STERIS (STE) | Ireland | $25.561B | 26.39 |
| DexCom (DXCM) | United States | $23.292B | 32.11 |
| Waters (WAT) | United States | $22.582B | 29.87 |
| Hologic (HOLX) | United States | $16.517B | 17.39 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.201B | 0.00 |
| Globus Medical (GMED) | United States | $11.241B | 23.59 |
| Penumbra (PEN) | United States | $10.916B | 76.79 |
| Masimo (MASI) | United States | $8.188B | 26.24 |
| Sysmex ADR (SSMXY) | Japan | $6.364B | 20.22 |
| Glaukos (GKOS) | United States | $5.273B | 0.00 |
| Teleflex (TFX) | United States | $4.837B | 7.71 |
| TransMedics (TMDX) | United States | $3.949B | 46.78 |
| Veracyte (VCYT) | United States | $3.152B | 35.92 |
| LivaNova (LIVN) | United Kingdom | $3.014B | 16.28 |
| Alphatec Holdings (ATEC) | United States | $3.001B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.384B | 11.19 |
| Artivion (AORT) | United States | $2.160B | 99.11 |
| Elekta AB (EKTAY) | Sweden | $1.775B | 17.20 |
| Nihon Kohden (NHNKY) | Japan | $1.739B | 15.18 |
| PROCEPT BioRobotics (PRCT) | United States | $1.700B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.189B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.155B | 0.00 |
| AxoGen (AXGN) | United States | $1.109B | 0.00 |
| IRadimed (IRMD) | United States | $1.075B | 51.21 |
| OPKO Health (OPK) | United States | $0.983B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.958B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.938B | 5.08 |
| SiBone (SIBN) | United States | $0.749B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.594B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.545B | 10.88 |
| Tactile Systems Technology (TCMD) | United States | $0.544B | 31.65 |
| AngioDynamics (ANGO) | United States | $0.507B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.492B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.441B | 0.00 |
| NeuroPace (NPCE) | United States | $0.427B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.424B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.419B | 11.56 |
| RxSight (RXST) | United States | $0.394B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.373B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.349B | 2.63 |
| Alpha Tau Medical (DRTS) | Israel | $0.328B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.304B | 50.65 |
| Spectral Diagnostics (EDTXF) | Canada | $0.255B | 0.00 |
| CVRx (CVRX) | United States | $0.234B | 0.00 |
| 908 Devices (MASS) | United States | $0.210B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.200B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.198B | 0.00 |
| Inogen (INGN) | United States | $0.187B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.156B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.147B | 0.00 |
| Neuronetics (STIM) | United States | $0.140B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.134B | 0.00 |
| Accuray (ARAY) | United States | $0.126B | 0.00 |
| LENSAR (LNSR) | United States | $0.122B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.104B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.092B | 0.00 |
| Hyperfine (HYPR) | United States | $0.083B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.079B | 0.00 |
| InspireMD (NSPR) | United States | $0.079B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.073B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.072B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| Spectral AI (MDAI) | United States | $0.051B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.046B | 0.00 | |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| DarioHealth (DRIO) | United States | $0.023B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.021B | 0.00 |
| Envoy Medical (COCH) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.015B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.010B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.005B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.39 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |